top of page

Executive Team

Under the leadership of Chief Executive Officer Thane Wettig, FibroGen’s executive team includes accomplished leaders with deep and broad experience. We are focused on delivering first-in-class medicines for the treatment of unmet medical needs.

Thane Wettig

Chief Executive Officer

David D_edited.jpg

David DeLucia, CFA

Chief Financial Officer

John Alden Headshot_edited_edited.jpg

John Alden

General Counsel

Our Leadership

We are putting substantial expertise to work in
developing and commercializing novel therapeutics.
 

bottom of page